Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus

Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus

Skeletal muscle wasting in patients with diabetes mellitus (DM) is a complication of decreased muscle mass and strength, and is a serious risk factor that may result in mortality. Deteriorated differentiation of muscle precursor cells, called myoblasts, in DM patients is considered to be one of the...

Full description

Bibliographic Details
Main Authors: Shunichi Nakamura, Shinichi Yonekura, Takeshi Shimosato, Tomohide Takaya
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Physiology
Subjects:
myogenetic oligodeoxynucleotide
skeletal muscle
myoblast
myogenic differentiation
diabetes mellitus
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2021.679152/full

Similar Items

Similar Items